Diagnostic and Biotech

2017 Animal Health Market Consolidation: Who will not survive

  • VPG2204564
  • 83 Pages
  • November 2017
  • Diagnostic and Biotech

- Will the industry consolidate, decentralize, or undergo a bimodal transformation?

- How will the current trends affect the major market segments?

- Which companies will enter the market and which will not survive?

This new 83-page report from VPGMarketResearch analyzes strategies, marketing tactics and
technological know-how of the worlds leading animal health companies, including:

  • Five-year forecasts for:

    - Major market segments

    - Key geographic regions

    Company Profiles

    Bayer Animal Health

    - Considering selling animal health division
    - Plans to invest in Kiel
    - Rising demand for collars
    - Focusing on parasiticides and anti-infectives
    - Strong position in parasiticides
    - Animal health R&D
    - Worldwide marketing network
    - Emerging markets
    - Re-registering existing products
    - Present structure
    - Diverse businesses
    - Challenged by animal disease outbreaks
    - Europe's premier research organization
    - Animal health R&D
    - Crop science segment
    - Monsanto acquisition
    - Chairman Werner Baumann
    - Supervisory board

    Boehringer Ingelheim

    - Sales and growth
    - Animal health is one of the major pillars
    - Swine vaccine Ingelvac circoflex
    - Merial animal health
    - U.S. animal health market position
    - Promoting Eqvalan line
    - Seeking to reinforce position in livestock market
    - Strategies supported by collaborations
    - Merial R&D programs
    - Collaborative efforts
    - Porcine Reproductive and Respiratory Syndrome (PRRS)
    - Decentralized R&D


    - Sales, growth and R&D investment
    - Biomune, Phylaxia and French sites
    - 2016 acquisitions
    - Hatcher automation and in-ovo vaccination
    - India acquisition
    - Brazil--important strategic market
    - Merial swine vaccines acquisition

    Elanco Animal Health

    - Strong technological base
    - Fermentation and chemical synthesis
    - Strong base in antibiotics and anticoccidials
    - Expiration of patents caused restructuring
    - US marketing
    - Lilly Japan
    - Focused marketing strategies
    - Well-established relationship with customers
    - Multi-disciplinary business with diverse product portfolio
    - In the midst of strategic decisions
    - Stepping up efforts to curtail time to market
    - Could divest animal health
    - Changed product mix
    - Strategic collaborations
    - Broadening portfolio of companion animal medicines
    - Hard look at bottom line
    - CEO Dave Ricks

    Merck Animal Health

    - Sales and growth
    - Higher sales of Bravecto
    - Valle acquisition
    - Extensive know-how in animal health
    - Sphereon technology
    - Expanding worldwide poultry business
    - Poultry biological research laboratories
    - Segmented poultry-product line
    - Mitigated generic competition
    - R&D productivity improving
    - Patents, economies of scale, and powerful intellectual base
    - Keytruda key to future

    Phibro Animal Health

    - Sales and growth
    - Extensive portfolio of antibiotics and antibacterials
    - Sales force, sales offices and distribution network
    - Animal health R&D facilities
    - Biotay acquisition


    - Sales and growth
    - Eli Lilly dog parasiticides acquisition
    - Product portfolio
    - Formulation know-how
    - Waltham nutrition products
    - Reorganized European distribution
    - Decentralized approach for food-producing animals
    - Benefitting from new companion animal products
    - Focusing on niche markets
    - Seeking expansion in the U.S.


    - Majority of revenue from production animals
    - Largest market share in the industry
    - Poultry and swine revenue declining
    - Scale allows to use own sales force in emerging markets
    - Management continues cost-cutting efforts
    - Reassessing manufacturing infrastructure
    - CEO Juan Ramon Alaix
    - Market-leading position in emerging markets
    - Leading share in Asia-Pacific, Canada and Latin America
    - Fragmented customer base
    - Leading position in fastest-growing markets

    Contains 83 pages and 6 tables

  • Please Select Format

    Enquiry About Report

    Need More Information

    Contact us
    + 1-800-910-6452
    +91 20 66346066
    --- or ---



    European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

    Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

    April 2018| $3390 | Pre Book Price:$2967

    World Surface Analysis Market - Opportunities and Forecasts, 2014 - 2020

    Surface analysis is a technique that provides a medium to correlate performance with thin film conformation. The analysis is used in the discovery of new materials and to enhance the ...

    April 2018| $5370 | Pre Book Price:$4699

    World Electrophoresis Market - Opportunities and Forecasts, 2015 - 2020

    Electrophoresis is a technique used for separation of proteins and nucleic acids. This technique is primarily used for RNA and DNA analysis. It is also used in biochemistry for separation ...

    April 2018| $5370 | Pre Book Price:$4699

    World Oxidative Stress Assay Market - Opportunities and Forecasts, 2015 - 2020

    Oxidative stress assay is used to determine level of oxidative stress markers and reagents in cells. Applications of oxidative stress assay are research laboratories and bioproduction. Assays detect generalized oxidative ...

    April 2018| $5370 | Pre Book Price:$4699

    European Microscopy Market - Opportunities and Forecasts, 2015 - 2020

    Microscopy is a field of science in which objects are not visible to bare eye can be viewed under microscope. It is used to observe macromolecules and macromolecular complexes at ...

    April 2018| $3390 | Pre Book Price:$2967

    World Immunoassay Market - Opportunities and Forecasts, 2015 - 2020

    Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity ...

    April 2018| $5370 | Pre Book Price:$4699

    2019 © Copyright Big Market Research

    View Pricing >>